openPR Logo
Press release

Fetal and Neonatal Heart Monitor Market to witness a CAGR of 5.50% during 2017-2028

10-23-2018 02:03 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Fetal and Neonatal Heart Monitor Market to witness a CAGR of 5.50%

Preterm birth is one of the most prevalent cause of stillbirths, or fetal mortality, and neonatal morbidity & mortality. In the U.S. alone, premature births account for nearly 10% of the newborn babies annually. Insufficient and improper nutrition delivery, a primary cause of preterm birth, has been lined with many health diseases and cardiovascular malignancies. Increase in the number of stillbirths on the coattails of preterm birth has raised concerns with regard to safety monitoring, such as heart rate monitoring.

Alterations in readings of heart rate in conventional fetal and neonatal heart monitor has created confusion among clinicians and patients in the past. False readings have further misled diagnosis and treatment, thereby posing high risk to fetus. Recognizing the concern, fetal and neonatal heart monitor manufacturers have introduced novel solutions in order to prevent false diagnosis and avoid ambiguities. Smart pulse fetal heart monitoring technology developed by Philips is one such novel development perceived in the market. This report envisages the fetal and neonatal heart monitor market to record a steady 5.5% value CAGR in the period of forecast, 2018 to 2028.

Request For Report Sample at https://www.factmr.com/connectus/sample?flag=S&rep_id=750

Opportunities Abound in Fetal and Neonatal Heart Monitors for Metabolic Disorder Induced Risks

Despite intensive efforts taken for interpretation of fetal and neonatal heart rate to prevent hypoxia, challenges prevail regarding complete diagnosis of heart rate pattern changes, particularly caused by metabolic disorders. New research approaches are being introduced for facilitating care of fetal and neonatal hypoxia cost-effectively, as a means to alleviate expensive and complication procedure related to computerized Cardiotocograph (CTG).

One of these approaches is to assess mobile resuscitation devices, which are particularly designed for simplifying newborn resuscitation at bedside through an intact cord, as iatrogenic interference with “auto-resuscitation” occurs post-separation of newborn babies from their placental transfusion. Another effective approach the use of CO breath analyzers during the period of labor, which is easy-to-use, speedy, and non-invasive technology. This technology enables identifying most frequent conditions causing metabolic academia and hypoxia.

Vested interest and rigid mindset of equipment manufacturers who seek lucrative medico-legal practices point at over-longstanding dependency on CTG. However, new research approaches being introduced have paved new avenues for manufacturers of fetal and neonatal heart monitor.

Fetal and Neonatal Heart Monitor: Novel Modality Developments Offering Framework for Non-Invasive Evaluation

Healthcare professionals recommend intrapartum fetal heart rate (FHR) monitor during labor for proper assessment of fetal wellbeing. Despite high penetration, fetal scalp electrode monitor and external Doppler have been deemed to have significant shortcomings, which in turn has led toward the development of non-invasive modality technologies as possible alternatives. Intrapartum fetal heart rate monitoring using Electronic Uterine Monitoring (EUM) is considered to be a notable development in the field.

Comparative analysis carried out between accuracy of FHR trace via novel EUM, and fetal scalp electrode monitor and external Doppler has shown accuracy of the former to be significant higher. Intrapartum FHR via EUM has been proved to be accurate and valid, offering higher yields in correlations with the internal scalp electrode monitoring and external Doppler. Such novel modality developments are likely to impart greater framework for intrapartum FHR’s non-invasive evaluation.

Report Analysis at https://www.factmr.com/report/750/fetal-and-neonatal-heart-monitor-market

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fetal and Neonatal Heart Monitor Market to witness a CAGR of 5.50% during 2017-2028 here

News-ID: 1322054 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Fetal

Global Fetal And Maternal Monitor Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Fetal And Maternal Monitor market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Growing awareness of maternal and fetal health, particularly in developing nations, is driving the market for
Fetal Monitoring: Top Companies Revenue Analysis
The Fetal Monitoring Market is expected to register a CAGR of 6.93% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Brochure @ https://www.theinsightpartners.com/sample/TIPMD00002260/?utm_source=OpenPR&utm_medium=10432 The List of Companies 1. NEOVENTA MEDICAL AB 2. NATUS MEDICAL INCORPORATED 3. SIEMENS HEALTHCARE 4. GENERAL ELECTRIC COMPANY 5. ANALOGIC CORPORATION 6. FUJIFILM SONOSITE 7. PHILIPS HEALTHCARE 8. OSI SYSTEMS, INC 9. MEDTRONIC PLC 10. GETINGE GROUP Fetal Monitoring Market Segmentation Product Product • Ultrasound Devices • Fetal Monitors • Telemetry
[Latest] Fetal Monitoring Systems Market : An Overview
The ""Fetal Monitoring Systems Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Fetal Monitoring Systems Market, 2024-2031 Verified Market Research's most recent report, ""Fetal Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,""
2022 Fetal Monitoring Market Analysis, Industry Demand, Size, Sales, Trends Oppo …
The report covers current market growths including market enlargement, partnerships & collaborations, mergers & acquisitions, and new product launches. Moreover, the study includes an absolute financial study, SWOT profile, business policies, newly launched products & services, and a business summary of the market players. This study stakeholders and new business entrants to understand the present market trends and convey new business tactics. It also outlines the strategies adopted by them
Fetal Monitoring Market Size to Reach Valuation of $4.25 Billion by 2027 | Elect …
Growth of the global fetal monitoring market is attributed to increase in incidences of stillbirths, multiple pregnancy, late maternal age, technological advancements, and increase in emphasis on continuous fetal monitoring. Furthermore, rise in investments by governments in healthcare system and hospitals are some of the factors that contribute to the growth of the market. The fetal monitoring market was valued at $2.93 billion in 2019 and is expected to reach $4.25
Fetal Monitoring Market
Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe